• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p21是40S核糖体S6激酶2的一个新的下游靶点。

p21 Is a Novel Downstream Target of 40S Ribosomal S6 Kinase 2.

作者信息

Basu Alakananda, Xuan Zhenyu

机构信息

Department of Microbiology, Immunology and Genetics, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.

Department of Biological Sciences, Center for Systems Biology, University of Texas at Dallas, Richardson, TX 75080, USA.

出版信息

Cancers (Basel). 2024 Nov 10;16(22):3783. doi: 10.3390/cancers16223783.

DOI:10.3390/cancers16223783
PMID:39594738
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11592183/
Abstract

: The ribosomal S6 kinase 2 (S6K2) acts downstream of the mechanistic target of rapamycin complex 1 and is a homolog of S6K1 but little is known about its downstream effectors. The objective of this study was to use an unbiased transcriptome profiling to uncover how S6K2 promotes breast cancer cell survival. : RNA-Seq analysis was performed to identify novel S6K2 targets. Cells were transfected with siRNAs or plasmids containing genes of interest. Western blot analyses were performed to quantify total and phosphorylated proteins. Apoptosis was monitored by treating cells with different concentrations of doxorubicin. : Silencing of S6K2, but not S6K1, decreased p21 in MCF-7 and T47D breast cancer cells. Knockdown of Akt1 but not Akt2 decreased p21 in MCF-7 cells whereas both Akt1 and Akt2 knockdown attenuated p21 in T47D cells. While Akt1 overexpression enhanced p21 and partially reversed the effect of S6K2 deficiency on p21 downregulation in MCF-7 cells, it had little effect in T47D cells. S6K2 knockdown increased mRNA and knockdown of cJun enhanced p21. Low concentrations of doxorubicin increased, and high concentrations decreased p21 levels in T47D cells. Silencing of S6K2 or p21 sensitized T47D cells to doxorubicin via c-Jun N-terminal kinase (JNK)-mediated downregulation of Mcl-1. : S6K2 knockdown enhanced doxorubicin-induced apoptosis by downregulating the cell cycle inhibitor p21 and the anti-apoptotic protein Mcl-1 via Akt and/or JNK.

摘要

核糖体S6激酶2(S6K2)作用于雷帕霉素机制靶点复合物1的下游,是S6K1的同源物,但其下游效应分子鲜为人知。本研究的目的是通过无偏差转录组分析来揭示S6K2如何促进乳腺癌细胞存活。:进行RNA测序分析以鉴定新的S6K2靶点。用小干扰RNA(siRNA)或含有感兴趣基因的质粒转染细胞。进行蛋白质免疫印迹分析以定量总蛋白和磷酸化蛋白。通过用不同浓度的阿霉素处理细胞来监测细胞凋亡。:在MCF-7和T47D乳腺癌细胞中,沉默S6K2而非S6K1会降低p21水平。在MCF-7细胞中,敲低Akt1而非Akt2会降低p21水平,而在T47D细胞中,同时敲低Akt1和Akt2会减弱p21水平。虽然Akt1过表达增强了p21,并部分逆转了S6K2缺陷对MCF-7细胞中p21下调的影响,但对T47D细胞几乎没有影响。敲低S6K2会增加mRNA,而敲低c-Jun会增强p21。低浓度的阿霉素会增加T47D细胞中的p21水平,高浓度则会降低p21水平。沉默S6K2或p21会通过c-Jun氨基末端激酶(JNK)介导的Mcl-1下调使T47D细胞对阿霉素敏感。:敲低S6K2通过Akt和/或JNK下调细胞周期抑制剂p21和抗凋亡蛋白Mcl-1,增强了阿霉素诱导的细胞凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/3be3473f9faa/cancers-16-03783-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/5189f16bba0a/cancers-16-03783-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/5ffec8b19c5d/cancers-16-03783-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/bc251ee629e8/cancers-16-03783-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/c1947a9e07c3/cancers-16-03783-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/4e09b65023de/cancers-16-03783-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/0d3eff89d548/cancers-16-03783-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/6b5df8505391/cancers-16-03783-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/1761bd4c9143/cancers-16-03783-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/e505f3832855/cancers-16-03783-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/3be3473f9faa/cancers-16-03783-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/5189f16bba0a/cancers-16-03783-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/5ffec8b19c5d/cancers-16-03783-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/bc251ee629e8/cancers-16-03783-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/c1947a9e07c3/cancers-16-03783-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/4e09b65023de/cancers-16-03783-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/0d3eff89d548/cancers-16-03783-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/6b5df8505391/cancers-16-03783-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/1761bd4c9143/cancers-16-03783-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/e505f3832855/cancers-16-03783-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/11592183/3be3473f9faa/cancers-16-03783-g010.jpg

相似文献

1
p21 Is a Novel Downstream Target of 40S Ribosomal S6 Kinase 2.p21是40S核糖体S6激酶2的一个新的下游靶点。
Cancers (Basel). 2024 Nov 10;16(22):3783. doi: 10.3390/cancers16223783.
2
Regulation of anti-apoptotic Bcl-2 family protein Mcl-1 by S6 kinase 2.S6激酶2对抗凋亡Bcl-2家族蛋白Mcl-1的调控
PLoS One. 2017 Mar 16;12(3):e0173854. doi: 10.1371/journal.pone.0173854. eCollection 2017.
3
S6 kinase 2 promotes breast cancer cell survival via Akt.S6 激酶 2 通过 Akt 促进乳腺癌细胞存活。
Cancer Res. 2011 Apr 1;71(7):2590-9. doi: 10.1158/0008-5472.CAN-10-3253. Epub 2011 Mar 22.
4
S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway.S6K1基因敲除/S6K2基因敲除小鼠表现出围产期致死性以及对雷帕霉素敏感的5'-末端寡嘧啶mRNA翻译,并揭示了一条丝裂原活化蛋白激酶依赖性S6激酶途径。
Mol Cell Biol. 2004 Apr;24(8):3112-24. doi: 10.1128/MCB.24.8.3112-3124.2004.
5
Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis.通过表达谱分析和结构分析揭示mTOR靶点S6K1和S6K2在乳腺癌中的不同作用
PLoS One. 2015 Dec 23;10(12):e0145013. doi: 10.1371/journal.pone.0145013. eCollection 2015.
6
Regulation of ribosomal S6 kinase 2 by effectors of the phosphoinositide 3-kinase pathway.磷酸肌醇3激酶途径效应物对核糖体S6激酶2的调节
J Biol Chem. 2001 Mar 16;276(11):7884-91. doi: 10.1074/jbc.M006969200. Epub 2000 Dec 6.
7
Ribosomal S6 kinase 2 inhibition by a potent C-terminal repressor domain is relieved by mitogen-activated protein-extracellular signal-regulated kinase kinase-regulated phosphorylation.有丝分裂原激活蛋白-细胞外信号调节激酶激酶调控的磷酸化作用可解除由一个有效的C末端阻遏结构域对核糖体S6激酶2的抑制。
J Biol Chem. 2001 Mar 16;276(11):7892-8. doi: 10.1074/jbc.M009972200. Epub 2000 Dec 6.
8
Characterization of S6K2, a novel kinase homologous to S6K1.S6K2的特性分析,一种与S6K1同源的新型激酶。
Oncogene. 1999 Sep 9;18(36):5108-14. doi: 10.1038/sj.onc.1202894.
9
Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer.mTOR 靶点 S6K1 和 S6K2 在乳腺癌中的临床潜力。
Breast Cancer Res Treat. 2011 Aug;128(3):713-23. doi: 10.1007/s10549-010-1058-x. Epub 2010 Oct 16.
10
Mutational analysis of ribosomal S6 kinase 2 shows differential regulation of its kinase activity from that of ribosomal S6 kinase 1.核糖体S6激酶2的突变分析表明,其激酶活性与核糖体S6激酶1的激酶活性存在差异调节。
Biochem J. 2003 Jul 15;373(Pt 2):583-91. doi: 10.1042/BJ20021794.

引用本文的文献

1
USF1-induced RPS6KB2 activation influences aggressive phenotype in B-cell non-Hodgkin lymphoma.USF1诱导的RPS6KB2激活影响B细胞非霍奇金淋巴瘤的侵袭性表型。
Hum Cell. 2025 Aug 31;38(5):154. doi: 10.1007/s13577-025-01284-x.